Light Chain Deposition Disease | UNC Kidney Center
Criteria for Presumptive Diagnosis of IgD Multiple Myeloma
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Kappa free light chain reduction ratio per patient and treatment protocol. | Download Table
Kappa and Lambda Light Chains - HealthTree for Multiple Myeloma
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma | Blood Cancer Journal
Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study - eBioMedicine
Monoclonal gammopathy of undetermined significance: A primary care guide | Cleveland Clinic Journal of Medicine
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | Wiener Medizinische Wochenschrift
Hemato | Free Full-Text | Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
Immunoglobulin light chain - Wikipedia
Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study - eBioMedicine
CaptureSelect™ KappaXL PhyTip columns for purification of human IgGs
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases